Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer-Reference-Cited by-同舟云学术

Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer

Published:2014-11 Issue:8 Volume:32 Page:1285-1291
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Mahal Brandon A.,Ziehr David R.,Aizer Ayal A.,Hyatt Andrew S.,Sammon Jesse D.,Schmid Marianne^ORCID,Choueiri Toni K.,Hu Jim C.,Sweeney Christopher J.,Beard Clair J.,D׳Amico Anthony V.,Martin Neil E.,Lathan Christopher,Kim Simon P.,Trinh Quoc-Dien^ORCID,Nguyen Paul L.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference30 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update;Partin;J Am Med Assoc,1997

3. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D׳Amico;J Am Med Assoc,1998

4. NCCN Clinical Practice Guidelines in Oncology. Prostate Cancer. Available at: 〈http://www.nccn.org〉; 2014 [accessed 30.12.2013].

5. Radical prostatectomy versus watchful waiting in early prostate cancer;Bill-Axelson;N Engl J Med,2011

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond the PSA: The hidden costs of screening in prostate cancer;Cancer;2024-07-16

2. A qualitative approach to understanding the drivers of unequal receipt of definitive therapy for Black men with prostate cancer in Massachusetts;Cancer;2024-06-04

3. Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care Systems;JAMA Network Open;2024-03-19

4. Racial disparity in the utilization of immunotherapy for advanced prostate cancer;Journal of the National Medical Association;2023-12

5. The costs and inequities of precision medicine for patients with prostate cancer: A call to action;Urologic Oncology: Seminars and Original Investigations;2023-09